<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="28748">Doxorubicin</z:chebi> (DXR) is one of the most effective <z:chebi fb="0" ids="35610">antineoplastic agents</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the optimal clinical use of this agent is limited because of marked <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Renin angiotensin system (<z:mp ids='MP_0011356'>RAS</z:mp>) plays an important role in the development of <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp>, reperfusion injury and <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="601027">Aliskiren</z:chebi> (ALK) is a direct inhibitor of renin and does not affect other systems involved in cardiovascular regulation </plain></SENT>
<SENT sid="4" pm="."><plain>This study was designed to explore the possible protective effects of ALK (30 and 100 mg/kg, per oral [p.o.] respectively for 42 days) in <z:hpo ids='HP_0011010'>chronic</z:hpo> model of DXR (1.25 mg/kg, intraperitoneally (i.p.) sixteen equal cumulative doses) induced <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in rats </plain></SENT>
<SENT sid="5" pm="."><plain>DXR treatment significantly (P&lt;0.01) increased the activities of serum <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase (CK-MB), <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase (LDH), cardiomyocyte caspase-3 and catalase (CAT) </plain></SENT>
<SENT sid="6" pm="."><plain>ALK (100 mg/kg) treatment prevented the animals significantly (P&lt;0.01) from rise in the above indices </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore ALK (100 mg/kg) significantly restores the DXR-induced decrease in <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defense, reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) and <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) </plain></SENT>
<SENT sid="8" pm="."><plain>Transmission electron microscopic studies showed that DXR caused <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in myocardium, manifested as condensation of chromatin network at the margins and rupture of nuclear membrane which was well protected by ALK (100 mg/kg) treatment </plain></SENT>
<SENT sid="9" pm="."><plain>The present study indicates that ALK protected rats from DXR-induced <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>